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Hoffmann, and Roseanne Armitage
Background: Subjective and objective measures of poor sleep in alcoholic insomniacs predict
relapse to drinking. Nonalcoholic insomniacs underestimate their total sleep time (TST) and over-
estimate their sleep onset latency (SOL) and wake time after sleep onset (WASO) compared with
polysomnography (PSG). This study evaluated 3 hypotheses: (1) subjective SOL would predict fre-
quency of future drinking; (2) participants would overestimate SOL and WASO and underestimate
TST; and (3) higher amounts of over- and underestimates of sleep at baseline would predict worse
drinking outcomes prospectively.
Methods: Participants (N5 18), mean age 44.6 years (13.2), underwent an adaptation night and
then 2 nights of PSG 3 weeks apart. They also provided morning estimates of SOL, WASO, TST, and
sleep efficiency (SE). Following the baseline PSG, participants were followed over 12 weeks. A 2-way
ANOVA (nightmethod of measuring sleep) compared results and regression analyses predicted
drinking. Drinking outcomes were defined as number of days drinking (DD) and number of heavy-
drinking days (HDD) during 2 consecutive 6-week follow-up periods.
Results: Most participants (72%) overestimated SOL by a mean of 21.3 (36) minutes compared
with PSG [F(1, 14)5 7.1, po0.03]. Unexpectedly, 89% underestimated WASO by a mean difference
of 48.7 (49) minutes [F(1, 14)5 15.6, po0.01]. Drinking during the first 6-week study period was
predicted by both subjective estimates of WASO and their accuracy, whereas drinking during the
second 6-week period was predicted by both subjective estimations of sleep and rapid eye movement
sleep latency.
Conclusion: Greater subjective accuracy of wakefulness at night provided by the patient predicted
drinking during the study. Unlike nonalcoholic insomniacs, this alcoholic sample significantly under-
estimated WASO compared with PSG values. The predictive ability of sleep parameters depended on
the selected measure of drinking outcomes and when outcomes were measured. Subjective sleep
measures were better predictors of future drinking than corresponding PSG measures.
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ALCOHOLHAS SOPORIFIC effects in nonalcoholicsubjects, but after chronic use, the effects on sleep
become deleterious. Within a night, alcohol has a biphasic
effect on sleep. Initially, sleep onset latency (SOL), or the
time it takes to fall asleep, is shortened and there is an
increase in slow-wave sleep (SWS) in the first half of the
night. In the second half of the night, sleep quality deteri-
orates and there are more awakenings (Rundell et al.,
1977). As alcohol use becomes more chronic, tolerance to
the sedating effects develops and individuals require great-
er amounts of alcohol more frequently to derive the same
sleep-promoting effects. As the neurochemical systems
of the brain adapt, sleep-promoting systems adapt their
responses to the chronic alcohol administration and sleep
propensity is dampened (Brower, 2003).
Sleep continues to be severely disturbed in early recovery
from alcohol dependence. A review of studies estimated
that 36% to 72% of participants in early recovery
from alcohol dependence complained of insomnia
(Brower, 2001). Cohn et al. (2003) found that 91% of
alcoholic participants had sleep disturbance as measured
by a well-validated measure of sleep disturbance: the Pitts-
burgh Sleep Quality Index (Buysse et al., 1989; Cohn et al.,
2003). These findings have been supported by earlier
experimental studies documenting complaints of sleep
disturbance during early recovery (Baekeland et al., 1974;
Brower et al., 2001; Caetano et al., 1998; Foster et al.,
2000; Mello and Mendelson, 1970). Both subjective com-
plaints of poor sleep and disrupted sleep measured by
polysomnography (PSG) have been shown in naturalistic
treatment outcome studies to predict relapse to drinking
among alcohol-dependent participants. For example,
Brower et al. (1998) found that SOL, whether measured
by PSG or self-report, predicted return to any drinking
within 5 months of starting treatment.
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Understanding how a patient perceives his or her sleep is
important because it may have an impact on the patient’s
future behaviors. It is well established that nonalcoholic
participants with insomnia are subjectively inaccurate:
they underestimate their total sleep time (TST) and over-
estimate SOL and the time they are awake in the night
after they fall asleep, i.e., wake time after sleep onset
(WASO), compared with same-night objective results of
PSG (Baekeland and Hoy, 1971; Carskadon et al., 1976;
Frankel et al., 1976; Kales and Kales, 1984; Monroe, 1967)
This misperception may contribute to sleep-disruptive
behaviors and dysfunctional beliefs about one’s sleep that
ultimately perpetuate factors in the course of the insomnia.
Misperception of sleep in a recovering alcohol-dependent
individual with insomnia may be additionally detrimental.
If a recovering alcoholic patient perceives his or her
sleep to be poor, then this perception may contribute to a
relapse to drinking.
Only one study has looked at the relationship between
subjective and objective assessments of sleep in a popula-
tion of alcoholic insomniacs (Currie et al., 2004). The
authors directly compared subjective reports of insomnia
(including sleep logs, questionnaires, and reports from the
patient’s partner and clinician) to wrist actigraphy, which
served as the objective measure of insomnia. Results from
1 week of simultaneous sleep log and actigraphy data
revealed that participants overestimated SOL by a mean
of 16 minutes, but accurately perceived sleep efficiency
(SE) and TST. In contrast to nonalcoholic insomniacs,
however, alcoholic participants underestimated WASO by
a mean of 1 hour. In other words, after falling asleep, they
perceived that they slept better than they actually did. This
finding was unexplained.
To further characterize an individual’s estimate of sleep
in this study, we used a sleep parameter that measures the
relationship between subjective estimates of sleep parame-
ters (obtained via sleep logs) and corresponding objective
sleep measures (obtained via PSG) for the same night of
sleep. This measure was termed the objective sleep time
estimated (OSE) score by Edinger and Fins (1995). The
score, expressed as a percentage, provides a quantitative
measure of accuracy that can be used as a standard
method to compare the accuracy of perceptions among
different sleep variables and subject groups. In particular,
it has been used to distinguish primary insomnia from sec-
ondary insomnia and to compare insomnia subgroups
(Means et al., 2003). It has also been used to compare sub-
jective estimates of sleep to actigraphy data in recovering
alcoholic patients postwithdrawal (Currie et al., 2004).
The present study extends the existing literature in sev-
eral ways. First, no study has conducted a quantitative
comparison of subjective sleep measures with PSG, the
gold standard of objective sleep measurement, in alcohol-
dependent insomnia participants. Actigraphy is only able
to detect the presence or absence of movement and there-
fore is an indirect measure of sleep. By contrast, PSG
provides direct quantitative measures of sleep architecture
(sleep stages) and continuity (e.g., SOL, TST, WASO). In
general, the relationship between objective and subjective
sleep measures is poorly understood, but studies are
particularly sparse among individuals with a history of
alcohol dependence because few insomnia trials include
alcohol-dependent participants.
This study includes only alcoholic participants with a
clinical diagnosis of insomnia, whereas previous sleep stud-
ies of alcoholic-dependent participants selected participants
meeting criteria for alcohol dependence only (cf. Brower
et al., 1998). No previous study has examined either the
subjective accuracy of sleep or the relationship between
the accuracy of these perceptions and future drinking
behavior in patients with alcohol dependence and comor-
bid insomnia. Additionally, this study adds to the existing
literature on impaired sleep and future drinking because,
instead of utilizing only a single dichotomous measure of
relapse (i.e., return to any drinking) over one time interval,
we utilized 2 drinking frequency measures [number of
drinking days (DD) and number of heavy drinking
days(HDD)] and assessed when drinking occurred (during
2 consecutive 6-week follow-up periods). We hypothesized
that subjective SOL in alcohol-dependent participants with
insomnia would predict drinking during both follow-up
periods. Second, we hypothesized that participants would
overestimate SOL and WASO, and underestimate TST,
and that the greater the subjective/objective discrepancies at
baseline (i.e., less accurate OSE scores), the worse drinking
outcomes would be during the follow-up periods.
MATERIALS AND METHODS
Participants
Twenty-one (10 women) insomnia participants in early recovery
from alcohol dependence were recruited from a local outpatient
alcohol treatment facility, or the community, by way of advertising.
All of these individuals were taking part as paid volunteers in a ran-
domized-controlled trial of the effects of gabapentin versus placebo
on relapse to alcohol use.
Procedures
Participants responded to flyers advertising a study for individuals
who ‘‘have problems sleeping’’ and who ‘‘use alcohol to help them
sleep.’’ Interested participants telephoned the study’s research coord-
inator and underwent an initial screening interview. The interview
consisted of questions relating to quantity and frequency of drinking,
date of last alcohol use, sleeping habits, medications, and psychiatric
history. Participants needed to express a desire to stop drinking or a
willingness to abstain from use of alcohol and other drugs of abuse
(except nicotine) throughout their participation in the study. A study
investigator (S.S.) evaluated data collected from a telephone screening
interview and determined whether or not an interested participant was
appropriate for further screening. At that time, a date and time were
set for a more comprehensive screening appointment. At the time of
appointment, participants verbally agreed to have a breath alcohol
content measurement taken. Written informed consent for additional
screening and research participation was obtained only if blood
alcohol levels were less than 0.05%.
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Participants were excluded if they met the following criteria: were
o18 years of age; met DSM-IV criteria for panic disorder, social pho-
bia, generalized anxiety disorder, posttraumatic stress disorder, major
depression, bipolar disorder, anorexia nervosa, or bulimia nervosa in
the past month; met criteria for dependence on any psychoactive
substance other than alcohol (except nicotine) in the past 1 month;
had a medical condition or chronic pain syndrome that caused insom-
nia; had insomnia that was associated with sleep apnea (Respiratory
Disturbance Index 410) or periodic limb movements (periodic limb
movement index with arousals 415) (determined via PSG); and
required treatment with medications known to affect sleep such
as mirtazepine, trazodone, tricyclic antidepressants, neuroleptics,
sedative hypnotics, stimulants, centrally acting antihistamines or anti-
hypertensives, oral corticosteroids, or theophylline. Patients were also
excluded if they were taking mood stabilizers or other antidepressants
only if there had been a recent change in the past 2 months in the
medications or a change was anticipated during the course of the study
or if the study investigator determined the medication or its under-
lying disorder was contributing to their insomnia.
Of the 35 participants who qualified for insomnia and who under-
went an in-person screening process, 14 were excluded: 7 who were
lost to follow-up before completing the screening process, 1 who was
referred for residential treatment, 1 who could not maintain absti-
nence from alcohol use through the screening period, 1 who did not
meet alcohol dependence criteria, 2 who had positive urine drug
screens for cocaine, 1 who was excluded based on PSG results indi-
cating severe sleep apnea, and 1 who was excluded based on PSG
results indicating periodic leg movement sleep disorder. In summary,
2 of 14 excluded subjects, or14%, were excluded due to other sleep
disorders besides primary insomnia.
Participants reported persistent insomnia for at least 1 week post-
abstinence with a score on the revised version of the Clinical Institute
Withdrawal Assessment for Alcohol (CIWA-A) of o8 (Sullivan
et al., 1989) to ensure that persisting insomnia was not due to acute
alcohol withdrawal. They were excluded if they rated their insomnia as
‘‘much improved’’ or ‘‘very much improved’’ on the Clinical Global
Impression Scale after 1 week of abstinence (Guy, 1976). Insomnia
was assessed and diagnosed by the authors (K.B. or S.S.) using the
Sleep Disorders Questionnaire (Douglass et al., 1994), the Sleep Prob-
lems Questionnaire (Jenkins et al., 1988), and the Insomnia Interview
Schedule (Morin, 1993). Participants meeting the above criteria were
scheduled to return for a baseline sleep assessment.
After completing the study instruments and measures in the
screening visit, participants were followed for a 7- to 14-day baseline
period. The purpose of this period was to promote and
assess for abstinence and to document persisting insomnia before
randomization. Participants were provided with a sleep log and
asked to record their sleep schedule. Participants also received a
nightly single-blind placebo capsule during baseline as a lead-in to
the 6-week medication trial.
At the conclusion of 1 week of abstinence, each eligible participant
was admitted to the University of Michigan General Clinical
Research Center (GCRC) sleep laboratory and underwent noctur-
nal PSG recordings on 2 consecutive nights. Upon arrival for each
study night, they were given a test for breath alcohol content and
were either excluded or rescheduled for any positive result. The first
night was an adaptation night to rule out occult sleep disorders.
After excluding subjects for an occult sleep disorder, the data from
this night were not used in any of the analyses. Therefore, the next
night of PSG was referred to as study ‘‘Night 1.’’ Participants
generally arrived in the laboratory at approximately 9:00 PM and left
between 7:00 and 8:00 AM the next day. Participants completed sleep
logs before leaving the laboratory each morning.
Following Night 1, qualified participants were randomized to
either placebo (n5 11) or gabapentin (n5 10) for 6 weeks as part of
a double-blind randomized-controlled trial. After 3 more weeks in
the study, participants returned for their final night of PSG, referred
to as ‘‘Night 2.’’ Upon morning awakening after each night, partic-
ipants provided estimates of their SOL, WASO, and TST in their
sleep log.
Of the 21 subjects who qualified, data for 2 participants were not
included because they did not report their subjective assessment of
sleep after Night 1. Data for another subject could not be made
available, leaving a total of 18 subjects for analysis.
Primary Outcome Measures
Objective Sleep. Objective sleep measurement consisted of an
electroencephalogram (C3/A2 EEG), referential electrooculogram
(EOG) with electrodes placed at the outer canthus of each eye, one
immediately above the other just below the horizontal plane, to
record both horizontal and vertical slow and rapid eye movements
(REM), submental electoromyogram (EMG), respiratory monitor-
ing (nasal-oral airflow monitor, abdominal and chest monitors of
respiratory effort, and ear or finger oximetry), electrocardiogram, and
EMG of the anterior tibialis muscle (to document periodic leg move-
ments). Data were recorded using a paperless system (Telefactor
Corp., Grass Technologies, West Warwick, RI). The primary PSG-
dependent variables were TST, SOL, WASO, and SE. In addition,
the percentage of time spent in Stages 1, 2, 3, and 4 and REM sleep
were determined, as was REM onset latency. Polysomnography
studies were scored by standard criteria (Rechtschaffen and Kales,
1968).
Subjective Sleep Estimates. Subjective sleep was measured via
sleep logs that were completed upon morning awakening from Night
1 and Night 2 in the laboratory. Estimates used in for this study
included SOL, WASO, and TST. Participants did not provide
estimates of SE. Rather, subjective SE for this study was calculated
by a research assistant, based on the ratio of subjectively estimated
TST divided by reported time in bed, and multiplied by 100. Thus,
SE is expressed as a percentage, and lower numbers are indicative of
greater sleep discontinuity.
Accuracy Measurements. To calculate the subjective accuracy of
each sleep parameter, a variation of the OSE (Edinger and Fins,
1995) was used. This measure is derived by using the following for-
mula: OSE5 (subjective parameter/objective parameter)100%. In
this formula, the subjective parameter is the sleep log estimate and
the objective measure is the PSG for the parameter being examined.
The OSE score for SE reflects the ratio of subjective SE that was cal-
culated by a research assistant divided by the SE value determined
polysomnographically. An OSE score of 100% indicates perfect
agreement between objective and subjective estimates; OSE o100%
indicates subjective underestimation relative to PSG; and 4100%
indicates subjective overestimation.
Alcohol Consumption. Daily alcohol consumption was obtained
using the Timeline Follow-Back Interview (TLFB) (Sobell et al.,
1988). Frequency of any drinking was defined by the number of DD
during a 6-week period. Frequency of heavy drinking (which com-
bines frequency and quantity) was defined as the number of HDD
during a 6-week period. Heavy drinking was defined as44 standard
drinks in a day for women and45 standard drinks in a day for men.
A standard drink is equivalent to 12 oz of beer, 5 oz of table wine, or
1 to 1.5 oz of liquor (NIAAA, 2005).
Data Analyses
A 2-way ANOVA of the sleep assessment method (sleep log vs
PSG) versus night (Night 1 vs Night 2) was computed for each of the
dependent variables SOL, WASO, TST, and SE, to examine within-
night and between-night differences in sleep parameters. Paired
t tests were also computed. Regression analyses were computed to
examine the relationships between Night 1 objective and subjective
measures of baseline sleep and subsequent alcohol consumption
during the 2 consecutive follow-up periods. The first 6-week period
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included medication treatment, and the second 6-week period did not.
Statistical analyses were performed by using SPSS (Version 13.0).
RESULTS
Sample Demographics
Eighteen participants (9 females) completed Night 1 only.
Fifteen participants (7 females) completed both Night 1 and
Night 2. Before entering the study, participants reported
having a mean (SD) of 31.2 (13) DD and 21.2 (16) HDD
in the past 90 days. Participants were abstinent in the week
before the randomization trial, except for 1 subject who had
2 drinks 4 days before the trial began. Independent sample
t tests revealed no differences between the gabapentin group
and placebo group on any of the subjective or objective
sleep measures for the pretreatment night or posttreatment
night; therefore, these groups were collapsed.
Objective Sleep by PSG from Night 1 to Night 2
The mean sleep parameters for Night 1 versus Night 2 are
displayed in Table 1. A paired sample t test was conducted
to evaluate the difference between study nights. There were
no differences between Night 1 and Night 2 sleep variables.
Subjective Versus Objective Accuracy
Using paired sample t tests and correlation coefficients,
the results comparing subjective estimates (log) and objec-
tive (PSG) sleep parameters within each night are shown
in Table 2. A 2-way within-groups analysis of variance
was conducted to explore the impact of night (Night 1 vs
Night 2) and assessment (objective PSG data vs subjective
sleep log) on subjective estimations only.
OnNight 1, there was a statistically significant main effect
for SOL assessment [F(1, 14)5 7.1, po0.03]. The partial Z2
statistic (0.34) indicated a large effect size (Cohen, 1988).
Post hoc comparison using a paired sample t test indicated
that the mean score for Night 1 subjective assessment of
SOL (48.149.2) minutes was significantly higher than the
objective data, 26.8 (29.9) minutes. Most (72%) partici-
pants overestimated SOL compared with PSG (po0.05),
with a groupmean of 21.3 (36) minutes and amean of 30.5
(36.7) minutes among the overestimators.
There was a statistically significant main effect forWASO
assessment [F(1, 14)5 15.6, po0.01]. The effect size was
large (partial Z2 5 0.53). The mean subjective assessment of
WASO was 38.2 (40.7) minutes, which was unexpectedly
lower than the objective data, 86.9 (34.5) minutes. The
majority (89%) of the participants underestimated WASO
by a mean difference of 48.7 (49.14) minutes for the
overall group and 58.8 (41.5) minutes among the under-
estimators. Assessments of TST or SE by log estimates did
not differ significantly from PSG values.
On Night 2, 11 of 15 participants (73%) overestimated
SOL by a mean of 17.09 (35.5) minutes compared with
PSG, although the effect was not significant (po.07).
Fourteen of 15 participants (93%) underestimated WASO
by 42.54 (78.3) minutes (po.02) (Table 2). Assessments
of TST or SE by log estimates did not differ significantly
from PSG values.
Median OSE scores were used to describe OSE scores,
because Kolmogorov-Smirnov tests of normality revealed
that 6 of the 8 OSE scores (except for Night 2 TST and SE)
were not normally distributed. These scores across the
2 study nights are displayed in Fig. 1. Participants consist-
ently underestimated WASO, with a median OSE score of
29% on Night 1 and 38% on Night 2. The median OSE
scores for SOL were 156 and 138%, indicating overesti-
mation on both nights. Participants were generally
accurate in their estimation of the number of hours they
slept (98 and 106%) and how well they slept, as indicated
by SE (97 and 104%). The degree of over- or underestima-
tion within each variable did not differ from Night 1 to
Night 2. A split-plot analysis of variance revealed that
there was no medication effect on OSE scores for SOL,
TST, SE, or WASO on Night 1 or Night 2.
Relationship with Drinking
A series of multiple regressions were conducted to exam-
ine the relationship between Night 1 objective sleep
parameters and subjective estimates of sleep and drinking
Table 1. Objective Sleep Measures
Sleep measure Night 1 (n 5 15) Night 2 p Value
Total sleep time (min) 317.5 (47.4) 303.5 (68.8) 0.27
Sleep onset latency (min) 28.4 (32.0) 35.3 (45.9) 0.39
Sleep efficiency (%) 77.4 (7.1) 75.7 (13.9) 0.63
Stage 1 (%) 14.1 (10.4) 13.0 (9.6) 0.47
Stage 2 (%) 55.7 (10.6) 59.2 (8.8) 0.27
Stage 3/4 (%) 11.2 (7.6) 12.8 (9.3) 0.45
REM (%) 19.0 (6.5) 14.9 (5.8) 0.11
REM latency (min) 97.8 (46) 110.9 (56.7) 0.43
Wake after sleep onset (min) 92.4 (32.3) 96.9 (57.5) 0.77
REM, rapid eye movement.












Night 1 (n 5 18)
SOL (min) 48.1 (49) 26.8 (30) 21.3 (36) 2.5
WASO (min) 38.2 (41) 86.9 (35) 48.7 (49) 4.2
SE (%) 76.09 (15) 79.0 (8) 2.9 (14) 0.9
TST (min) 324.0 (92) 328.94 (51) 4.97 (75) 0.3
Night 2 (n 5 15)
SOL (min) 62.5 (58) 35.3 (46) 17.1 (36) 2.0
WASO (min) 48.3 (58) 96.91 (58) 42.5 (78) 3.1
SE (%) 70.7 (24) 75.7 (14) 2.8 (20) 0.5
TST (min) 286.9 (103) 303.5 (68) 5.1 (73) 0.3
po0.05; po0.001.
SOL, sleep onset latency; WASO, wake time after sleep onset; SE,
sleep efficiency; TST, total sleep time; PSG, polysomnography.
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variables after controlling for previous drinking (number
of DD or HDD) and treatment group (i.e., either
gabapentin or placebo). Baseline drinking frequencies and
medication group were entered as control variables into
the regression analyses to predict subsequent alcohol
consumption from baseline sleep parameters. Initial
analyses using logistic regression to predict any drinking
versus no drinking revealed no significant relationships
between sleep variables and drinking and therefore HDD
and DD were analyzed as outcome measures.
The more accurate participants were at detecting periods
of wakefulness in their sleep during the study, the more
alcohol they consumed and the more frequently they
drank. Frequency of heavy drinking (HDD) during the
first 6-week follow-up period was predicted by both sleep-log
subjective estimates and OSE scores of WASO (R2 5 0.69,
po0.02, and R2 5 0.49, po0.02, respectively). Similarly,
frequency, expressed as DD during this phase, was pre-
dicted by sleep-log subjective estimates of WASO and
accuracy (R2 5 0.53, po0.03, and R2 5 0.55, po0.02,
respectively). Overestimation of SOL was not predictive
of drinking during the outpatient study phase.
The single objective variable that significantly predicted
relapse was REM sleep latency (R2 5 0.59, po0.05). After
controlling for treatment group and previous days drink-
ing, baseline REM latency predicted HDD during the first
6 weeks, such that the longer the REM latency, the more
the HDD. Polysomnography measures of SOL, TST, SE,
WASO, REM sleep percentage, and sleep stages 1 to 4 did
not predict any drinking outcomes.
In the second 6 weeks, the following variables were pre-
dictive of HDD: OSE scores of SOL (R2 5 0.67, po0.03),
subjective estimates of SOL (R2 5 0.58, po5 0.05), OSE
scores of WASO (R2 5 0.53, po0.05), and OSE scores of
SE (R2 5 0.70, po0.02). Days drinking were predicted by
OSE scores of SE (R2 5 0.51, po0.05), subjective estima-
tions of TST (R2 5 0.79, po0.02), and the accuracy (OSE
scores) of TST estimations (R2 5 0.49, p5 0.05).
DISCUSSION
The primary aim of the study was to evaluate the associ-
ation between objectively measured sleep and the subjective
estimates of sleep in a sample of alcohol-dependent partic-
ipants with insomnia. The secondary aim was to examine
objective and subjective indices of sleep as predictors of
drinking outcomes during a 12-week follow-up period, div-
ided into 2 consecutive 6-week blocks. There were 4 main
study findings. First, as expected and similar to nonalcohol-
ic insomnia participants, most participants overestimated
SOL. However, unlike nonalcoholic insomnia participants,
this alcoholic sample significantly underestimated WASO
compared with actual PSG values. Second, subjective sleep
measures (SOL andWASO)were better predictors of future
drinking than corresponding PSGmeasures. Third, the pre-
dictive ability of baseline sleep parameters depended on the
selected measure of drinking outcomes and when the out-
come was measured (i.e., during the first or second 6-week
follow-up period). Finally, there were no changes in objec-
tive or subjective sleep measures, including OSE scores,
from Night 1 to Night 2.
Subjective Estimates
Subjective sleep estimates, collected from sleep logs, and
their accuracy, reported as OSE percentages, revealed a
consistent underestimation of WASO among participants
and across the study nights (Fig. 1). These findings,
although counter to our original hypothesis, are consistent
with Currie et al. (2004), who found that alcohol-dependent
insomnia participants similarly underestimated WASO. In
that study, the median WASO OSE scores were 70.7%,
which was higher than our findings of 29 and 38% on
Night 1 and Night 2, respectively. Two factors may
account for these discrepancies. First, Currie et al. (2004)
used wrist actigraphy, which measures activity level, an
indirect measure of sleep, rather than PSG and, therefore,
may have detected less wakefulness during the night. Acti-
graphs do underestimate awakenings if no motor activity
accompanies the arousal (Hoffmann et al., 2004). Second,
participants in the Currie study were abstinent for an aver-
age of 15.7 (20.2) months, whereas the mean duration of
abstinence in the present study was only 20 days. Thus,
changes in objective sleep over prolonged abstinence may
be associated with changes in subjective sleep, but little is
known about this relationship. It is also possible that par-
ticipants become more aware of wakefulness in the night
with prolonged abstinence, a well-documented character-
istic of chronic insomnia participants (Rosa and Bonnet,
2000). Overall, these results suggest that alcohol-depend-
ent participants in early recovery may not initially report
















SOL TST WASO SE
Night One
Night Two
Fig. 1. Objective sleep time estimated scores across following 2 nights of
study for each sleep variable. Greater than 100% represent overestimation of
the respective variable and less than 100% represent underestimation of the
respective variable. The horizontal bar at 100% represents perfect accuracy.
Objective sleep time estimated scores demonstrate a consistent underesti-
mation of WASO both across subjects and across the 2 study nights. SOL,
sleep onset latency; WASO, wake time after sleep onset; SE, sleep efficiency;
and TST, total sleep time; OSE, objective sleep time estimated.
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wakefulness in the night, even though sleep disruption is
evident on the PSG. Additionally, they may be more likely
to report difficulty falling asleep than waking during the
night. This may be due, at least in part, to preexisting trait
characteristics such as heightened anxiety sensitivity.
The mechanisms underlying the evolution of the insom-
nia complaint in alcohol-dependent participants are
not known. As alcohol affects many of the same areas of
the brain that are involved in the initiation and regulation
of sleep (for a review, see Brower, 2001, 2003), it is tempt-
ing to speculate that neurotoxicity from chronic alcohol
use may be affecting the memory for, and perceptual
distinction of, wakefulness and sleep upon morning awak-
ening. The particular pattern of WASO underestimation
observed in this study may be a characteristic of insomnia
in early recovery among this subpopulation.
Predicting Relapse
Overestimation of SOL on the sleep logs and accuracy by
OSE percentages of SOL were predicted drinking only
during weeks 7 to 12 of the study, Although it has been well
documented that subjectively reported SOL predicts relapse
in alcohol-dependent participants (Brower et al., 1998,
2001; Drummond et al., 1998; Foster et al., 1998; Foster
and Peters, 1999; Skoloda et al., 1979), the current study
focused on additional variables and their relationship
between drinking behaviors during different follow-up
periods. Our findings suggest that difficulty falling asleep
may present the greatest risk for relapse once the patient
finishes an episode of treatment for alcohol dependence.
Subjective estimation of WASO on sleep logs as well as
OSE WASO percentages were better predictors of drink-
ing during the first 6 weeks. Wake time after sleep onset
has not been shown to predict relapse in previous studies
of alcohol-dependent participants (Brower et al., 1998;
Foster and Peters, 1999). However, the results from the
present study may differ from previous studies because
participants enrolled in this study were selected because
of an insomnia complaint, not simply because they were
recovering alcohol-dependent patients. Furthermore, the
sample population differs from those studied in other
naturalistic studies (Cohn et al., 2003; Foster et al., 1998;
Foster and Peters, 1999) in that it reflects only those alco-
hol-dependent patients with insomnia in the absence of
other occult sleep disorders (e.g. sleep apnea), use other
drugs of abuse, and comorbid disorders. Therefore, one
must consider the external validity and how this sample
differs from a ‘‘typical’’ alcoholic population. Neverthe-
less, these results suggest that different rates and degrees of
relapse may be associated with the particular type of
insomnia complaint in recovering alcoholic patients.
Overall, this study suggests that subjective impressions of
sleep were better predictors of relapse than PSG measures.
Unlike previous studies (Brower et al., 1998; Drummond
et al., 1998), objectively determined SOL by PSG did not
predict relapse. The percent of SWS also did not predict
relapse, contrary to some previous findings (Aldrich et al.,
1999; Allen et al., 1977), but consistent with others (Brower
et al., 1998; Gann et al., 2004; Gillin et al., 1994).
The only objective measure that predicted relapse was
REM sleep latency. However, these findings indicate an
association between a long REM sleep latency on Night 1
and the quantity of DD during the second 6-week follow-
up period. This finding is inconsistent with previous
studies (Aldrich et al., 1994; Allen and Wagman, 1975;
Brower et al., 1998; Clark et al., 1998; Freemon, 1982;
Gann et al., 2001; Gillin et al., 1994), which showed that a
short REM latency predicted relapse.
There were limitations to this study. First, there were no
direct comparisons with age-matched and sex-matched
nonalcoholic insomniac controls. Second, the sample size
was small. Finally, because it has been suggested that cog-
nitive profile (Bastien et al., 2003), personality (Dorsey and
Bootzin, 1997), and sleep-related beliefs (Edinger et al.,
2000) impact subjective assessments of sleep, additional
sleep-related questionnaires may have provided more
information about a given participant’s sleep-related
thoughts and behaviors. A strength of the study was that
despite the small sample size, the subjective findings were
relatively strong. Attention to subjective reports in a clin-
ical setting and questionnaire data in the research setting
should be emphasized.
Clinical Implications
The results of the present study have important impli-
cations for understanding and managing alcoholic
participants with insomnia. First, such patients may be
prone to overestimate initial insomnia and underestimate
middle insomnia. When targeting insomnia with treatment,
therefore, both initial and middle insomnia should be consid-
ered even though one type of insomnia may generate the
complaint. Second, both subjective estimates of sleep and
their accuracy compared with objective sleep measures
may predict future drinking better than objective meas-
ures alone. Therefore, the use of sleep logs and subjective
sleep assessments may be a useful tool in the clinic. More-
over, normalization of PSG in the presence of persisting
sleep complaints may be an insufficient goal of treatment.
Nevertheless, health care professionals working with
recovering alcohol-dependent participants with insomnia
should consider referring their participants for a more
extensive sleep evaluation if initial treatment efforts
despite continuing abstinence fail to rule out sleep apnea
and periodic limb movement disorder.
In conclusion, we found that alcohol-dependent insom-
nia participants early in recovery overestimate SOL and
underestimate the amount of wakefulness in sleep. In
addition, the study highlights a potential distinction
between insomnia complaints in recovering alcoholic
patents versus nonalcoholic participants. This pattern of
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sleep perception may be a signature characteristic of
this insomnia subpopulation and directly contribute to
relapse, but this requires further study.
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